Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:Q9UIJ5 (
Rec
)
58,342
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Thyrotropin-releasing hormone (TRH) stimulates prolactin production in cultured GH3 rat anterior pituitary tumor cells. For correlation of cell-by-cell prolactin distribution and intracellular hormone concentration, GH3 cells were grown to plateau-phase density on glass coverslips in plastic dishes.
Acetone
-fixed, cell-bearing coverslips were stained for prolactin by an immunoglobulin-peroxidase bridge technique (Mason et al., '69); cells on the plastic dishes were assayed for prolactin (microcomplement fixation immunoassay, Tashjian, '73) and protein content. Intracellular prolactin, unaffected quantitatively by acetone fixation and choice of substratum, was localized immunocytochemically by a granular brown precipitate, abolished if anti-prolactin serum was preabsorbed with rat prolactin or omitted from the protocol. Intracellular prolactin was maximized with colchicine (5.0 X 10(-6) M; final 3 hr of incubation) in control and TRH-treated (10 ng/ml; 48 hr) GH3 cell cultures. A total of 8,500 cells were classified by light microscopy as unstained, heavily (H) or moderately (M) stained for prolactin. In controls, 35% of cells were prolactin-positive: 5% H and 29% M. After TRH, 45% were positive: 7% H and 38% M. Although prolactin-positive cells were unevenly distributed, comprising 25% to 46% of cells in individual microscopic fields in controls, TRH increased the proportion of M cells in all areas. TRH treatment raised prolactin levels to 450% of control, but mathematical analysis attributed less than 30% of the increase to new prolactin-positive cells. We conclude that TRH acts on GH3 cultures principally by raising the mean hormone content of individual positive cells rather than by increasing the proportion of cells committed to prolactin production.
Anat
Rec
1980 Jun
PMID:Immunocytochemical analysis of prolactin production by monolayer cultures of GH3 rat anterior pituitary tumor cells: I. Long-term effects of stimulation with thyrotropin-releasing hormone (TRH). 677 30
The health and housing of the stock on 26 organic dairy herds in four counties in eastern Sweden were studied for one year. The herds ranged in size from 12 to 64 cows, and their milk production from 3772 to 10,334 kg per cow per year. A large-animal practitioner visited the farms three times during the year, and a random sample of a third of the cows in each herd were examined. The calves and young stock and their housing were also studied. The calves were in good condition in all but four herds; their serum immunoglobulins varied from almost none to high levels. The young stock were in good condition and in good housing in 20 herds. No cows with clinical signs of metabolic disorders were found. Body condition scores were adequate or good except in two herds.
Acetone
was analysed in milk samples from individual cows three to six weeks postpartum, and only sporadic cases with high levels were found. The incidence of diseases treated by a veterinarian was lower in the organic herds than the average for the conventional herds in the local dairy association. The findings at the farm visits supported these data, and it is evident that a good standard of health and welfare can be achieved in organic dairy herds.
Vet
Rec
2002 Apr 20
PMID:Health of cows, calves and young stock on 26 organic dairy herds in Sweden. 1201 24